CYTO(CYTO)
CYTO
No analyst ratings available
No analyst price targets available for CYTO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E |
|---|---|
| Revenue Avg | $6M |
| Low | $6M |
| High | $6M |
| EBITDA Avg | $-1M |
| Low | $-1M |
| High | $-1M |
| EBIT Avg | $-1M |
| Low | $-1M |
| High | $-1M |
| Net Income Avg | $-707,142 |
| Low | $-707,142 |
| High | $-707,142 |
| EPS Avg | $-1.44 |
| Low | $-1.44 |
| High | $-1.44 |
| Analysts (Rev / EPS) | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $9,572 | $8,395 | $7,362 | $6,456 |
| Low | $9,572 | $8,395 | $7,362 | $6,456 |
| High | $9,572 | $8,395 | $7,362 | $6,456 |
| EBITDA Avg | $-1,914 | $-1,678 | $-1,472 | $-1,291 |
| Low | $-1,914 | $-1,678 | $-1,472 | $-1,291 |
| High | $-1,914 | $-1,678 | $-1,472 | $-1,291 |
| EBIT Avg | $-1,914 | $-1,678 | $-1,472 | $-1,291 |
| Low | $-1,914 | $-1,678 | $-1,472 | $-1,291 |
| High | $-1,914 | $-1,678 | $-1,472 | $-1,291 |
| Net Income Avg | $-90,829 | $-96,909 | $-87,219 | $-92,065 |
| Low | $-90,829 | $-96,909 | $-87,219 | $-92,065 |
| High | $-90,829 | $-96,909 | $-87,219 | $-92,065 |
| EPS Avg | $-0.43 | $-0.46 | $-0.42 | $-0.44 |
| Low | $-0.43 | $-0.46 | $-0.42 | $-0.44 |
| High | $-0.43 | $-0.46 | $-0.42 | $-0.44 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |